Extracellular Signal-regulated Kinase 1/2 Activity is Not Required in Mammalian Cells During Late G2 for Timely Entry into or Exit from Mitosis
Overview
Molecular Biology
Affiliations
Extracellular signal-regulated kinase (ERK)1/2 activity is reported to be required in mammalian cells for timely entry into and exit from mitosis (i.e., the G2-mitosis [G2/M] and metaphase-anaphase [M/A] transitions). However, it is unclear whether this involvement reflects a direct requirement for ERK1/2 activity during these transitions or for activating gene transcription programs at earlier stages of the cell cycle. To examine these possibilities, we followed live cells in which ERK1/2 activity was inhibited through late G2 and mitosis. We find that acute inhibition of ERK1/2 during late G2 and through mitosis does not affect the timing of the G2/M or M/A transitions in normal or transformed human cells, nor does it impede spindle assembly, inactivate the p38 stress-activated checkpoint during late G2 or the spindle assembly checkpoint during mitosis. Using CENP-F as a marker for progress through G2, we also show that sustained inhibition of ERK1/2 transiently delays the cell cycle in early/mid-G2 via a p53-dependent mechanism. Together, our data reveal that ERK1/2 activity is required in early G2 for a timely entry into mitosis but that it does not directly regulate cell cycle progression from late G2 through mitosis in normal or transformed mammalian cells.
Zhou X, Wu H Brief Bioinform. 2025; 26(1.
PMID: 39831891 PMC: 11744636. DOI: 10.1093/bib/bbaf009.
The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilities.
Hinneh J, Gillis J, Moore N, Butler L, Centenera M Front Oncol. 2022; 12:982231.
PMID: 36033439 PMC: 9400171. DOI: 10.3389/fonc.2022.982231.
DUSP7 regulates the activity of ERK2 to promote proper chromosome alignment during cell division.
Guo X, Ramirez I, Garcia Y, Velasquez E, Gholkar A, Cohn W J Biol Chem. 2021; 296:100676.
PMID: 33865857 PMC: 8131738. DOI: 10.1016/j.jbc.2021.100676.
Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.
Schulz E, Klampfl P, Holzapfel S, Janecke A, Ulz P, Renner W Nat Commun. 2014; 5:5191.
PMID: 25307848 PMC: 4214414. DOI: 10.1038/ncomms6191.
Ihermann-Hella A, Lume M, Miinalainen I, Pirttiniemi A, Gui Y, Peranen J PLoS Genet. 2014; 10(3):e1004193.
PMID: 24603431 PMC: 3945187. DOI: 10.1371/journal.pgen.1004193.